Clinical Trial Update: A Phase 1 Study of LY2787106 in Cancer and Anemia [Phase 1]

View source ↗

Summary

A Phase 1 study of LY2787106 in cancer and anemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• LY2787106

Snippet

Sponsor: Eli Lilly and Company | Conditions: Anemia | Phase 1 | Status: COMPLETED | Results posted: 2018-10-03